Almost 30 years after it was first licensed as a treatment for breast cancer, aromatase inhibitor anastrozole has been cleared for preventive use in women at high risk of
Just a year after it was launched, the UK’s Our Future Health research programme has signed up its millionth volunteer, a fifth of the way to its target of five million.
An intriguing UK study has found that people who get urgent referrals for suspected cancer, but were found not to have cancer after all, had a higher-than-expected risk ov
US start-up Samay has reported clinical data showing that its Sylvee wearable device can accurately diagnose chronic obstructive pulmonary disease (COPD), and even predict
Bayer has launched a digital patient support package in England designed to help people with type 2 diabetes look after the health of their kidneys and avoid progression t
The FDA has started a priority review of X4 Pharma’s mavorixafor, angling to become the first therapy for the rare disease WHIM syndrome, with a decision due by 30th April